Search hospitals > Illinois > Hinsdale
Sudarshan K Sharma MD Limited-Gynecologic Oncology
Claim this profileHinsdale, Illinois 60521
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Ovarian Cancer
Conducts research for Fallopian Tube Cancer
Conducts research for Adenocarcinoma
65 reported clinical trials
1 medical researcher
Summary
Sudarshan K Sharma MD Limited-Gynecologic Oncology is a medical facility located in Hinsdale, Illinois. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Fallopian Tube Cancer, Adenocarcinoma and other specialties. Sudarshan K Sharma MD Limited-Gynecologic Oncology is involved with conducting 65 clinical trials across 94 conditions. There are 1 research doctors associated with this hospital, such as Sudarshan Sharma, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Recurrence
Global LeaderStage IV
BRCA1 positive
BRCA2 positive
Top PIs
Clinical Trials running at Sudarshan K Sharma MD Limited-Gynecologic Oncology
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Serous Cystadenocarcinoma
Adenocarcinoma
Fallopian Tube Serous Adenocarcinoma
Ovarian Carcinoma
Peritoneal Tumors
Ovarian Tumors
Peritoneal Serous Adenocarcinoma
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
Surgical Procedures
for Reducing Ovarian Cancer Risk
This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sudarshan K Sharma MD Limited-Gynecologic Oncology?
Sudarshan K Sharma MD Limited-Gynecologic Oncology is a medical facility located in Hinsdale, Illinois. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Fallopian Tube Cancer, Adenocarcinoma and other specialties. Sudarshan K Sharma MD Limited-Gynecologic Oncology is involved with conducting 65 clinical trials across 94 conditions. There are 1 research doctors associated with this hospital, such as Sudarshan Sharma, MD.